Treatment of recurrent cervical cancer with cis-platinum and mitomycin C: a phase II study.

Abstract

Twenty-three patients with nonresectable, recurrent cancer of the cervix were treated with a combination of cis-platinum and Mitomycin C. The overall response rate was 35% in 20 evaluable patients. Four patients (20%) achieved a complete response with a median duration of 9 months. Three patients (15%) achieved a partial response with a median duration of… (More)

Topics

Cite this paper

@article{Malviya1989TreatmentOR, title={Treatment of recurrent cervical cancer with cis-platinum and mitomycin C: a phase II study.}, author={Vinay K. Malviya and Gunter Deppe and Manja Schoenmaker}, journal={American journal of clinical oncology}, year={1989}, volume={12 5}, pages={438-41} }